These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 9454629
21. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo. Gilbert ME, Lasley SM. Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801 [Abstract] [Full Text] [Related]
22. Postischemic reperfusion of the spinal cord: prolonged reperfusion alleviates the metabolic alterations induced by 25 min ischemia in the cervical and thoracolumbal segments. Ondrejicková O, Stolc S, Ziegelhöffer A, Horáková L, Styk J, Dzurba A, Schaur RJ. Gen Physiol Biophys; 2000 Dec; 19(4):415-26. PubMed ID: 11409844 [Abstract] [Full Text] [Related]
23. Effect of repetitive ischemic preconditioning on spinal cord ischemia in a rabbit model. Yu QJ, Wang YL, Zhou QS, Huang HB, Tian SF, Duan DM. Life Sci; 2006 Sep 05; 79(15):1479-83. PubMed ID: 16707140 [Abstract] [Full Text] [Related]
24. Spinal cord protection: effect of N-methyl-D-aspartate receptor antagonist MK-801 for spinal cord ischemia in a rabbit model. Tobinaga S. Kurume Med J; 2000 Sep 05; 47(1):45-53. PubMed ID: 10812889 [Abstract] [Full Text] [Related]
25. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia. Yam PS, Dunn LT, Graham DI, Dewar D, McCulloch J. J Cereb Blood Flow Metab; 2000 May 05; 20(5):772-9. PubMed ID: 10826527 [Abstract] [Full Text] [Related]
26. In vivo treatment with the K+ channel blocker 4-aminopyridine protects against kainate-induced neuronal cell death through activation of NMDA receptors in murine hippocampus. Ogita K, Okuda H, Watanabe M, Nagashima R, Sugiyama C, Yoneda Y. Neuropharmacology; 2005 May 05; 48(6):810-21. PubMed ID: 15829253 [Abstract] [Full Text] [Related]
28. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity. Osborne NN, Wood JP, Cupido A, Melena J, Chidlow G. Invest Ophthalmol Vis Sci; 2002 May 05; 43(5):1456-64. PubMed ID: 11980861 [Abstract] [Full Text] [Related]
29. Neuroprotective synergy of N-methyl-D-aspartate receptor antagonist (MK801) and protein synthesis inhibitor (cycloheximide) on spinal cord ischemia-reperfusion injury in rats. Liang CL, Yang LC, Lu K, Hsu HC, Cho CL, Chen SD, Huang HY, Chen HJ. J Neurotrauma; 2003 Feb 05; 20(2):195-206. PubMed ID: 12675972 [Abstract] [Full Text] [Related]
30. Effects of NMDA receptor antagonists following spinal ischemia in the rabbit. Martinez-Arizala A, Rigamonti DD, Long JB, Kraimer JM, Holaday JW. Exp Neurol; 1990 Jun 05; 108(3):232-40. PubMed ID: 2161775 [Abstract] [Full Text] [Related]
31. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on ischemic brain damage induced by four-vessel occlusion in rats. Okada M, Fujimura Y, Ueda H, Kometani M, Nakao K, Inukai T. Arzneimittelforschung; 1997 Feb 05; 47(2):115-9. PubMed ID: 9079228 [Abstract] [Full Text] [Related]
32. Effects of spinal cord ischemia on evoked potential recovery and postischemic regional spinal cord blood flow. Osenbach RK, Hitchon PW, Mouw L, Yamada T. J Spinal Disord; 1993 Apr 05; 6(2):146-54. PubMed ID: 8504227 [Abstract] [Full Text] [Related]
33. [Effect of calcium entry blocker, nimodipine, on the cerebral function and metabolic recovery following experimental cerebral ischemia]. Mabe H, Takagi T, Umemura S, Ohno M, Nagai H. No To Shinkei; 1985 Nov 05; 37(11):1067-72. PubMed ID: 2934079 [Abstract] [Full Text] [Related]
34. Status of the neonatal rat brain after NMDA-induced excitotoxic injury as measured by MRI, MRS and metabolic imaging. Dijkhuizen RM, van Lookeren Campagne M, Niendorf T, Dreher W, van der Toorn A, Hoehn-Berlage M, Verheul HB, Tulleken CA, Leibfritz D, Hossmann KA, Nicolay K. NMR Biomed; 1996 Apr 05; 9(2):84-92. PubMed ID: 8887373 [Abstract] [Full Text] [Related]
35. Calorie sources and recovery from central nervous system ischemia. Cherian L, Peek K, Robertson CS, Goodman JC, Grossman RG. Crit Care Med; 1994 Nov 05; 22(11):1841-50. PubMed ID: 7956290 [Abstract] [Full Text] [Related]
36. Pharmacologic studies of the neuroprotective actions of a glutamate antagonist in ischemia. Kochhar A, Zivin JA, Mazzarella V. J Neurotrauma; 1991 Nov 05; 8(3):175-86. PubMed ID: 1839396 [Abstract] [Full Text] [Related]
37. Energy metabolism in the dog's spinal cord after prolonged partial ischaemia and recirculation. Chavko M, Danielisová V. Physiol Bohemoslov; 1980 Nov 05; 29(1):49-53. PubMed ID: 6444738 [Abstract] [Full Text] [Related]
38. [Glutamate neurotoxicity during spinal cord ischemia--neuroprotective effects of glutamate receptor antagonists]. Nakamichi T. Jpn J Thorac Cardiovasc Surg; 1998 Sep 05; 46(9):854-9. PubMed ID: 9796285 [Abstract] [Full Text] [Related]
39. Efficacy of a new neuroprotective agent, gacyclidine, in a model of rat spinal cord injury. Feldblum S, Arnaud S, Simon M, Rabin O, D'Arbigny P. J Neurotrauma; 2000 Nov 05; 17(11):1079-93. PubMed ID: 11101210 [Abstract] [Full Text] [Related]
40. Modulation of ischemic signal by antagonists of N-methyl-D-aspartate, nitric oxide synthase, and platelet-activating factor in gerbil hippocampus. Zabłocka B, Lukasiuk K, Lazarewicz JW, Domańska-Janik K. J Neurosci Res; 1995 Feb 01; 40(2):233-40. PubMed ID: 7745616 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]